H
HRTX
Heron Therapeutics Inc
1.18
-0.01-0.84%After Hours: 1.220 +0.040 +3.39%17:33 02/20 EST
OPEN/PREV CLOSE1.200/1.190
TODAY RANGE1.160-1.205
VOL839.12K
MARKET CAP216.37M
52 WEEK RANGE0.9999-2.680
AVG VOL (3M)1.59M
% TURNOVER0.46%
TURNOVER--
P/E (TTM)-14.5859
% RANGE3.78%
EPS(TTM)-0.0809
P/E(FORWARD)-10.7273
P/B14.53
BVPS0.0812
DIVIDEND--
P/S1.244
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP213.99M
SHARES OUTSTANDING183.36M
NEXT EARNINGS02/25-03/02
FREE FLOAT181.35M
LOT SIZE1
EX-DATE01/13/2014
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Heron: Near The Bottom Of A Trading Range Despite Positives
TipRanks·01/09 18:28
Heron Therapeutics Reports Strong Preliminary Q4 2025 Revenue
Dow Jones·01/09 16:45
Heron Therapeutics Price Target Maintained With a $6.00/Share by HC Wainwright & Co.
TipRanks·01/09 16:25
H.C. Wainwright Sticks to Its Buy Rating for Heron Therapeutics (HRTX)
Dow Jones·01/09 15:53
Heron Therapeutics Rises on Expected 4Q, FY25 Revenue Beat
Seeking Alpha·01/09 15:15
Heron rises as preliminary revenue figures exceed estimates
TipRanks·01/09 14:35
Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M
Dow Jones·01/09 14:30
*Heron Therapeutics Sees 4Q Rev $40.5M >HRTX
Dow Jones·01/09 14:30
*Heron Therapeutics Sees FY25 Rev $154.9M >HRTX
Reuters·01/09 14:29
Heron Therapeutics Reports Preliminary Q4 2025 Net Revenue of $40.5 Million
Reuters·01/09 14:29
HERON THERAPEUTICS INC - REPORTS Q4 2025 NET REVENUE OF $40.5 MLN
Same Industry
Name/Symbol
Change%
Price